MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$38,585K
EPS
-$0.15
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Impairment of operating lease right-of-use assets and related property and equipment
-
-
0
0
Loss on disposal of property and equipment
-
-
0
0
Total revenue, net
45,689
26,218
21,194
20,923
Cost of sales
20,468
24,568
28,643
24,445
Research and development expenses, net
27,898
21,210
27,892
27,430
Selling, general and administrative expenses
41,161
39,953
36,280
30,265
Loss from operations
-43,838
-59,513
-71,621
-61,217
Other income, net
181
100
84
135
Foreign exchange gains (losses), net
460
-2,667
-911
1,499
Interest income
1,877
2,469
4,382
5,234
Interest expense, net
-2,674
11,124
10,520
-6,829
Total other income (expenses), net
5,192
-11,222
-6,965
13,697
Net loss before income tax
-38,646
-70,735
-78,586
-47,520
Income tax expense
465
863
532
397
Net loss
-39,111
-71,598
-79,118
-47,917
Foreign currency exchange translation adjustment
538
-1,130
-5,868
18,990
Unrealized holding (losses) gains on available-for-sale debt securities, net of tax of 0, 0, 0 and 0, respectively
-12
-141
86
-22
Total other comprehensive income (loss), net of tax
526
-1,271
-5,782
18,968
Total comprehensive loss
-38,585
-72,869
-84,900
-28,949
Basic EPS
-0.15
-0.27
-0.3
-0.18
Diluted EPS
-0.15
-0.27
-0.3
-0.18
Basic Average Shares
266,158,829
266,143,425
266,141,431
266,141,411
Diluted Average Shares
266,158,829
266,143,425
266,141,431
266,141,411
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Foreign currency
exchange translation...
$538K
(-97.17%↓ Y/Y)
Total comprehensive
loss
-$38,585K
(-33.29%↓ Y/Y)
Total other
comprehensive income (loss),...
$526K
(-97.23%↓ Y/Y)
Unrealized holding
(losses) gains on...
-$12K
(45.45%↑ Y/Y)
Net loss
-$39,111K
(18.38%↑ Y/Y)
Interest expense, net
-$2,674K
(60.84%↑ Y/Y)
Interest income
$1,877K
(-64.14%↓ Y/Y)
Foreign exchange gains
(losses), net
$460K
(-69.31%↓ Y/Y)
Other income, net
$181K
(34.07%↑ Y/Y)
Net loss before
income tax
-$38,646K
(18.67%↑ Y/Y)
Income tax expense
$465K
(17.13%↑ Y/Y)
Total other income
(expenses), net
$5,192K
(-62.09%↓ Y/Y)
Product
$45,672K
(118.29%↑ Y/Y)
License
$17K
Loss from operations
-$43,838K
(28.39%↑ Y/Y)
Total revenue, net
$45,689K
(118.37%↑ Y/Y)
Selling, general and
administrative expenses
$41,161K
(36.00%↑ Y/Y)
Research and development
expenses, net
$27,898K
(1.71%↑ Y/Y)
Cost of sales
$20,468K
(-16.27%↓ Y/Y)
Buy us a coffee
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)